These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 28195120

  • 1. β-lactam susceptibility in extended-spectrum β-lactamase-producing isolates.
    Agrawal GN, Rahangdale HD, Walawalkar AW.
    Indian J Pathol Microbiol; 2017; 60(1):142-143. PubMed ID: 28195120
    [No Abstract] [Full Text] [Related]

  • 2. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
    Yoshizumi A, Ishii Y, Aoki K, Testa R, Nichols WW, Tateda K.
    J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
    [Abstract] [Full Text] [Related]

  • 3. Detection of gram-negative β-lactamase producing pathogens in the clinical lab.
    Thomson KS.
    Curr Pharm Des; 2013 Feb; 19(2):250-6. PubMed ID: 22894616
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC, Hsueh PR.
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria--I. Steady-state treatment.
    Frère JM.
    Biochem Pharmacol; 1989 May 01; 38(9):1415-26. PubMed ID: 2785796
    [Abstract] [Full Text] [Related]

  • 10. New β-lactam antibiotics and β-lactamase inhibitors.
    Bush K, Macielag MJ.
    Expert Opin Ther Pat; 2010 Oct 01; 20(10):1277-93. PubMed ID: 20839927
    [Abstract] [Full Text] [Related]

  • 11. Accuracy of in vitro susceptibility tests for carbapenemase-producing Gram-negative bacteria.
    Sun J, Xu Y, Yu Y, Ni Y.
    J Med Microbiol; 2015 Jun 01; 64(6):620-622. PubMed ID: 25873580
    [Abstract] [Full Text] [Related]

  • 12. Defining an extended-spectrum beta-lactamase.
    Livermore DM.
    Clin Microbiol Infect; 2008 Jan 01; 14 Suppl 1():3-10. PubMed ID: 18154524
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Overcoming β-lactam resistance in Gram-negative pathogens.
    Bush K.
    Future Med Chem; 2016 Jun 01; 8(9):921-4. PubMed ID: 27228233
    [No Abstract] [Full Text] [Related]

  • 15. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control.
    Stürenburg E, Mack D.
    J Infect; 2003 Nov 01; 47(4):273-95. PubMed ID: 14556752
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metallo-β-lactamases: a last frontier for β-lactams?
    Cornaglia G, Giamarellou H, Rossolini GM.
    Lancet Infect Dis; 2011 May 01; 11(5):381-93. PubMed ID: 21530894
    [Abstract] [Full Text] [Related]

  • 20. Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory.
    Kim SY, Hong SG, Moland ES, Thomson KS.
    J Clin Microbiol; 2007 Sep 01; 45(9):2798-801. PubMed ID: 17596358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.